Canada · Health Canada Drug Product Database

KYMRIAH

A source-listed medicine record.

Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.

Medicine identity

Source reference: 97104
DIN: 02480514
Form: Suspension
Company as listed by source: NOVARTIS PHARMACEUTICALS CANADA INC
Source status: Marketed (2019-05-24)
Source last updated: 2026-04-02

Source-listed ingredients

TISAGENLECLEUCEL — 600000000 CELLS

These values do not establish equivalence or a dose recommendation.

Packages

10 To 50 Ml

Source and coverage

Open Health Canada Drug Product Database →

Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.

Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.

Browse Canada records →